• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KCPREDICT的开发与验证:一种用于早期检测川崎病患者冠状动脉病变的深度学习模型

Development and Validation of KCPREDICT: A Deep Learning Model for Early Detection of Coronary Artery Lesions in Kawasaki Disease Patients.

作者信息

Yang Lei, Shen Xiaoyu, Liu Yiman, Chen Jiangang, Zou Yuwen, Xu Lihao, Ji Wei, Zhang Yuqi, Liu Tingliang, Cao Qing

机构信息

Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

Department of Pediatrics, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

出版信息

Pediatr Cardiol. 2025 Jan 18. doi: 10.1007/s00246-024-03762-9.

DOI:10.1007/s00246-024-03762-9
PMID:39825907
Abstract

Kawasaki disease (KD) is a febrile vasculitis disorder, with coronary artery lesions (CALs) being the most severe complication. Early detection of CALs is challenging due to limitations in echocardiographic equipment (UCG). This study aimed to develop and validate an artificial intelligence algorithm to distinguish CALs in KD patients and support diagnostic decision-making at admission. A deep learning algorithm named KCPREDICT was developed using 24 features, including basic patient information, five classic KD clinical signs, and 14 laboratory measurements. Data were collected from patients diagnosed with KD between February 2017 and May 2023 at Shanghai Children's Medical Center. Patients were split into training and internal validation cohorts at an 80:20 ratio, and fivefold cross-validation was employed to assess model performance. Among the 1474 KD cases, the decision tree model performed best during the full feature experiment, achieving an accuracy of 95.42%, a precision of 98.83%, a recall of 93.58%, an F1 score of 96.14%, and an area under the receiver operating characteristic curve (AUROC) of 96.00%. The KCPREDICT algorithm can aid frontline clinicians in distinguishing KD patients with and without CALs, facilitating timely treatment and prevention of severe complications. The use of the complete set of 24 diagnostic features is the optimal choice for predicting CALs in children with KD.

摘要

川崎病(KD)是一种发热性血管炎疾病,冠状动脉病变(CALs)是其最严重的并发症。由于超声心动图设备(UCG)的局限性,早期检测CALs具有挑战性。本研究旨在开发并验证一种人工智能算法,以区分KD患者中的CALs,并在入院时支持诊断决策。使用包括基本患者信息、五种经典KD临床体征和14项实验室测量值在内的24个特征开发了一种名为KCPREDICT的深度学习算法。数据收集自2017年2月至2023年5月在上海儿童医学中心诊断为KD的患者。患者按80:20的比例分为训练队列和内部验证队列,并采用五折交叉验证来评估模型性能。在1474例KD病例中,决策树模型在全特征实验中表现最佳,准确率为95.42%,精确率为98.83%,召回率为93.58%,F1分数为96.14%,受试者操作特征曲线下面积(AUROC)为96.00%。KCPREDICT算法可帮助一线临床医生区分有和没有CALs的KD患者,促进及时治疗并预防严重并发症。使用全套24个诊断特征是预测KD患儿CALs的最佳选择。

相似文献

1
Development and Validation of KCPREDICT: A Deep Learning Model for Early Detection of Coronary Artery Lesions in Kawasaki Disease Patients.KCPREDICT的开发与验证:一种用于早期检测川崎病患者冠状动脉病变的深度学习模型
Pediatr Cardiol. 2025 Jan 18. doi: 10.1007/s00246-024-03762-9.
2
Accuracy of Machine Learning in Discriminating Kawasaki Disease and Other Febrile Illnesses: Systematic Review and Meta-Analysis.机器学习在鉴别川崎病和其他发热性疾病中的准确性:系统评价和荟萃分析。
J Med Internet Res. 2024 Nov 18;26:e57641. doi: 10.2196/57641.
3
Progression prediction of coronary artery lesions by echocardiography-based ultrasomics analysis in Kawasaki disease.基于超声组学分析的超声心动图在川崎病冠状动脉病变进展预测中的作用。
Ital J Pediatr. 2024 Sep 18;50(1):185. doi: 10.1186/s13052-024-01739-1.
4
A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study.用于美国儿童多系统炎症综合征和川崎病诊断的机器学习算法:回顾性模型开发和验证研究。
Lancet Digit Health. 2022 Oct;4(10):e717-e726. doi: 10.1016/S2589-7500(22)00149-2.
5
Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.川崎病可能出现面神经麻痹,表明冠状动脉病变。
Clin Rheumatol. 2021 Oct;40(10):4191-4197. doi: 10.1007/s10067-021-05791-8. Epub 2021 May 31.
6
Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.临床指标联合 S100A12/TLR2 信号分子建立川崎病冠状动脉病变新的评分模型。
PLoS One. 2023 Oct 12;18(10):e0292653. doi: 10.1371/journal.pone.0292653. eCollection 2023.
7
Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.红细胞分布宽度作为川崎病患者冠状动脉病变的预测指标
Pediatr Cardiol. 2021 Oct;42(7):1496-1503. doi: 10.1007/s00246-021-02633-x. Epub 2021 May 25.
8
Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.血浆蛋白质组学分析显示,SERPINE1 是与川崎病冠状动脉病变相关的潜在生物标志物。
Int Immunopharmacol. 2024 Sep 30;139:112698. doi: 10.1016/j.intimp.2024.112698. Epub 2024 Jul 18.
9
Multicenter Validation of a Machine Learning Algorithm for Diagnosing Pediatric Patients with Multisystem Inflammatory Syndrome and Kawasaki Disease.用于诊断多系统炎症综合征和川崎病儿科患者的机器学习算法的多中心验证
medRxiv. 2022 Feb 8:2022.02.07.21268280. doi: 10.1101/2022.02.07.21268280.
10
Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.基于 C 反应蛋白水平预测川崎病患儿冠状动脉病变:一项回顾性队列研究。
J Pediatr (Rio J). 2023 Jul-Aug;99(4):406-412. doi: 10.1016/j.jped.2023.02.005. Epub 2023 Mar 25.

本文引用的文献

1
Clinical Presentation and Management of Multisystem Inflammatory Syndrome in Children With COVID-19: A Systematic Review.新型冠状病毒肺炎患儿多系统炎症综合征的临床表现与管理:一项系统评价
Cureus. 2023 Oct 12;15(10):e46918. doi: 10.7759/cureus.46918. eCollection 2023 Oct.
2
Coronary artery dilation in children with febrile illnesses other than Kawasaki disease: A case report and literature review.川崎病以外的发热性疾病患儿的冠状动脉扩张:一例报告及文献综述
Heliyon. 2023 Oct 29;9(11):e21385. doi: 10.1016/j.heliyon.2023.e21385. eCollection 2023 Nov.
3
The state of play in tools for predicting immunoglobulin resistance in Kawasaki disease.
预测川崎病免疫球蛋白耐药性的工具现状。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1273-1279. doi: 10.1080/1744666X.2023.2238122. Epub 2023 Jul 19.
4
A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.一项关于川崎病合并冠状动脉瘤患者的注册研究(KIDCAR):启动三年后的多中心前瞻性注册研究报告
Eur J Pediatr. 2023 Feb;182(2):633-640. doi: 10.1007/s00431-022-04719-x. Epub 2022 Nov 25.
5
Imaging Evaluation of Kawasaki Disease.川崎病的影像学评估。
Curr Cardiol Rep. 2022 Oct;24(10):1487-1494. doi: 10.1007/s11886-022-01768-4. Epub 2022 Aug 20.
6
Temporal Correlation Between Kawasaki Disease and Infectious Diseases in South Korea.韩国川崎病与传染病的时间相关性。
JAMA Netw Open. 2022 Feb 1;5(2):e2147363. doi: 10.1001/jamanetworkopen.2021.47363.
7
Kawasaki Disease- Management Strategies Given Symptoms Overlap to COVID-19: A Review.川崎病-鉴于症状与 COVID-19 重叠的管理策略:综述。
JNMA J Nepal Med Assoc. 2021 Apr 30;59(236):417-424. doi: 10.31729/jnma.5698.
8
Seasonal Trends of Viral Prevalence and Incidence of Kawasaki Disease: A Korea Public Health Data Analysis.川崎病病毒流行率和发病率的季节性趋势:一项韩国公共卫生数据分析。
J Clin Med. 2021 Jul 27;10(15):3301. doi: 10.3390/jcm10153301.